IgG glycation and function during continuous ambulatory peritoneal dialysis

Nephrology Dialysis Transplantation

Volumn 12, Issue 2, 1997, Pages 310-314

  Davin, J C ^a   Bouts, A H M ^a   Krediet, R T ^b   Van Der Weel, M ^b   Weening, R S ^a   Groothoff, J ^a   Out, T A ^b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

CAPD; Complement activation; IgG glycation; Peritoneal dialysis; Phagocytosis; Staphyloccocus aureus

Indexed keywords

COMPLEMENT COMPONENT C3C; GLUCOSE; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G;

ADULT; AFFINITY CHROMATOGRAPHY; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; GLYCATION; HUMAN; HUMAN CELL; INFECTION CONTROL; NEUTROPHIL; PERITONEAL CAVITY; PH; PHAGOCYTOSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; COMPLEMENT ACTIVATION; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PHAGOCYTOSIS;

EID: 0031040317     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.2.310     Document Type: Article

References (23)

1. Lamperi S, Carozzi S. Defective opsonic activity of peritoneal effluent during continuous ambulatory peritoneal dialysis: importance and prevention. Perit Dial Bull 1986; 6: 87-92
2. Coles GA, Alobaid HMM, Topley N et al. Opsonic activity of dialysis effluent predicts those at risk of Staphylococcus epidermidis. Nephrol Dial Transplant 1987; 2: 359-365
3. Mac Gregor SJ, Brock JH, Briggs JD et al. Relationship of IgG, C3 and transferrin with opsonizing and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis. Nephrol Dial Transplant 1987; 2: 551-556
4. Zemel D, Struik AG, Krediet RT, Koomen GCM, Arisz L. No relationship between dialysate IgG and peritonitis incidence. Nephrol Dial Transplant 1989; 4: 755-756
5. De Vecchi AF, Kopple JD, Young GA et al. Plasma and dialysate immunoglobulin G in continuous ambulatory peritoneal dialysis patients: a multicenter study. Am J Nephrol 1990; 10: 451-456
6. Ashwell G, Morell AG. The dual role of sialic acid in the hepatic recognition and catabolism of serum glycoproteins. Biochem Soc Symp 1974; 40: 117-125
7. Leatherbarrow RJ, Rademacher TW, Dwek RA, Woof JM, Clark A, Burton DR. Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement C1 and interaction with human monocytes Fc receptor. Mol Immunol 1985; 22: 406-410
8. Peppard JV, Hobs SM, Jackson LE. Role of carbohydrate in binding of IgG to the Fc receptor of neonatal rat enterocyte. Mol Immunol 1989; 26: 495-501
9. Wieland OH. Protein modification by non-enzymatic glycosylation: possible role in the development of diabetic complications. Mol Cell Endocrinol 1983; 29: 125-131
10. Dolhofer-Bliesener R, Gerbitz KD. Impairment by glycation of immunoglobulin G Fc fragment function. Scand J Clin Lab Invest 1990; 50: 739-746
11. Rümke HC, Terpstra FG, Huis B, Out TA, Zeijlemaker WP. Immunoglobulin production in human mixed lymphocytes cultures and healthy donors. J Immunol 1982; 128: 696-701
12. Ruths S, Driedijk PC, Weening RS, Out TA. ELISA procedures for the measurement of IgG subclass antibodies to bacterial antigens. J Immunol Methods 1991; 140: 67-71
13. Bredius RGM, Driedijk PC, Schouten MFJ, Weening RS, Out TA. Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b and tetanus toxoid. Infect Immunol 1992; 60: 4838-4842
14. Gordon DL, Rice J, Finlay-Jones JJ, McDonald PJ, Hostetter MK. Analysis of C3 deposition and degradation on bacterial surfaces after opsonization. J Infect Dis 1988; 157-161
15. Bredius RGM, Vries CEE, Troelstra A et al. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type b opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional FcgammaRIIa polymorphism to IgG2. J Immunol 1993; 151: 1463-1473
16. Martin E, Bahkdi S. Flow cytometric assay for quantifying opsonophagocytosis and killing of Staphyloccocus aureus by peripheral blood leucocytes. J Clin Microbiol 1992; 30: 2246-2249
17. Pedersen FB, Ryttov N, Dellurun P, Drogsholt C, Kildeberg P. Acetate versus lactate in peritoneal dialysis solution. Nephron 1985; 39: 55-58
18. Krediet RT, Koomen GCM, Koopman MG et al. The peritoneal transport of serum proteins and neutral dextran in CAPD patients. Kidney Int 1989; 35: 1064-1072
19. Ruderman NB, Williamson JR, Brownly M. Glucose and diabetic vascular disease. FASEB J 1992; 6: 2905-2914
20. Dolhofer-Bliesener R, Lechner B, Gerbitz D. Impaired immunoglobulin G Fc fragment function in diabetics is caused by a mechanism different of glycation. Eur J Clin Chem Clin Biochem 1994; 32: 329-336
21. Young GA, Kendall S, Brownjohn AM. Complement activation during CAPD. Nephrol Dial Transplant 1993; 8. 1372-1375
22. Reddingius RE, Schröder CH, Daha MR, Willems HL, Koster AM, Monnens LAH. Complement in serum and dialysate in children on continuous ambulatory peritoneal dialysis. Perit Dial Int 1995; 15: 49-53
23. Lewis SL, Van Epps DE, Chenoweth DE. C5a receptor modulation on neutrophils and monocytes from chronic hemodialysis and peritoneal dialysis patients. Clin Nephrol 1986; 26: 37-44